A review of psilocybin clinical trials found that serious adverse events were extremely rare and typically resolved with proper therapeutic support. Most side effects—like mild anxiety, nausea, or transient increases in blood pressure—were temporary and managed through careful screening, preparation, and monitoring. The findings emphasize that strong safety protocols and trained therapist presence are key to maintaining psilocybin’s excellent safety record in clinical use.